Apheresis Market Value Expected to Touch $4,200.6 Mn by 2023 : Allied Market Research

"The demand for biopharmaceuticals extracted from plasma has continued to increase, replenishing plasma components around the world, which is further fueled by the growth of the appetite market. Increases in blood shortages and increased incidence of blood diseases also promote the adoption of an ablation system primarily through blood centers and hospitals."

Allied Market Research published a new report "Apheresis Market by Product, Method, Procedure, Component, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023". The global apheresis market was valued at $2,560.4 million in 2016, and is projected to reach $4,200.6 million by 2023, growing at a CAGR of 7.3% from 2017 to 2023. The disposable & reagents segment accounted for four-ninths of the total market share in 2016.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2855

The collection system supports collection and separation of blood components for donation. In addition, the system can perform removal or replacement of blood components for therapeutic procedures. The American Red Cross provides a wide range of therapeutic ingredients in the United States, including plasmapheresis, photopheresis, LDL affrees, and stem cell harvesting. In addition, the Center has hired qualified professionals with accessibility and availability, as well as qualified staff. As the number of blood centers around the world increases, the growth of the appetite market is greatly promoted.

Also, the increase in government-led projects that promote the development of countries such as China and India is driving market growth. For example, Twitter recently launched a social initiative called BloodMatters in India in March 2018. Twitter worked with Blood Donors, a voluntary donation help line. Also, in 2014, the number of blood donations in China increased and the number of blood centers nationwide increased. This situation has a positive impact on market growth.

The centrifugation method generated the highest revenue in 2016, and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that centrifugation is considered to be a standard method for apheresis, and is highly favored by the blood industry across the globe. However, the membrane separation segment is expected to register the highest growth rate during the forecast period, owing to rise in demand for membrane separation apheresis, as it prevents the need for replacement fluids by not depleting the blood coagulation factors.

Based on procedure, the market is divided into donor/automated apheresis and therapeutic apheresis. Donor/automated apheresis is anticipated to dominate the global market throughout the forecast period, due to increase in gap between blood supply and blood products, which facilitate the need for using apheresis machines. Moreover, rise in apheresis procedures across several specialties such as hematology, neurology, and oncology has contributed towards the robust growth displayed by this segment. The therapeutic apheresis is expected to grow at the highest rate from 2017 to 2023.

Key Findings of the Apheresis Market:

• The platelets (plateletpheresis) segment is expected to register the highest growth rate from 2017 to 2023.
• Blood centers accounted for maximum revenue in 2016, and is anticipated to maintain this trend throughout the forecast period.
• North America dominated the global apheresis market, accounting for maximum share in 2016, and is expected to retain the same trend during the forecast period.
• Intermittent flow centrifugation segment dominated the centrifugation apheresis market in 2016 and is expected to maintain this trend during the forecast period.
• Photopheresis is estimated to exhibit the highest CAGR of 9.3% from 2017 to 2023 in the therapeutic apheresis market.

Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, upsurge in disposable income, and rise in patient awareness towards blood donation. In addition, increase in incidence of dengue across countries in the Asia-Pacific region is the key contributor for the market growth in the region.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2855

The major companies profiled in this report include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd. Other prominent players in the value chain include Grifols International SA, Baxter International Inc., CSL Behring, Immucor, Becton, Dickinson & Co., Abbott Laboratories, Medicap, and Bioelettronica.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.